title: Expression of CD38 in human neuroblastoma SH-SY5Y cells.
abstract: Human CD38 antigen is a 42-45 kDa type II transmembrane glycoprotein with a short N-terminal cytoplasmic domain and a long C-terminal extracellular region. It is widely expressed in different cell types including thymocytes, activated T cells, and terminally differentiated B cells (plasma cells) and it is involved in cellular proliferation and adhesion. CD38 acts as an ectocyclase that converts NAD+ to the Ca2+ -releasing second messenger cyclic ADP-ribose (cADPR). It has been also demonstrated that increased extracellular levels of NAD+ and cADPR are involved in inflammatory diseases and in cellular damage, such as ischemia. In the present study, we have characterized the expression of CD38 in human neuroblastoma SH-SY5Y cell line. All-trans-retinoic acid (ATRA) treatment was used to induce cell differentiation. Our results indicate that: a) even if SH-SY5Y cells have a negative phenotype express CD38 at nuclear level, ATRA treatment does not influence this pattern; b) CD38 localizing to the nucleus may co-localize with p80-coilin positive nuclear-coiled bodies; c) purified nuclei, by Western blot determinations using anti-CD38 antibodies, display a band with a molecular mass of approximately 42 kDa; d) SH-SY5Y cells show nuclear ADP-ribosyl cyclase due to CD38 activity; e) the basal level of CD38 mRNA shows a time-dependent increase after treatment with ATRA. These results suggest that the presence of constitutive fully functional CD38 in the SH-SY5Y nucleus has some important implications for intracellular generation of cADP-ribose and subsequent nucleoplasmic calcium release.
authors.affiliation: Department of Molecular Pathology and Innovative Therapies, Histology Section, Marche Polytechnic University, Ancona, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Orciani
authors.forename: O
authors.initials: O
authors.lastname: Trubiani
authors.forename: G
authors.initials: G
authors.lastname: Cavaletti
authors.forename: S
authors.initials: S
authors.lastname: Guarnieri
authors.forename: E
authors.initials: E
authors.lastname: Salvolini
authors.forename: G
authors.initials: G
authors.lastname: Tredici
authors.forename: R
authors.initials: R
authors.lastname: Di Primio
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000032:analysis* / Q000235:genetics / Q000502:physiology; D045744:Cell Line, Tumor; D006801:Humans; D008562:Membrane Glycoproteins / Q000032:analysis* / Q000235:genetics / Q000502:physiology; D009447:Neuroblastoma / Q000737:chemistry*; D012333:RNA, Messenger / Q000032:analysis; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D014212:Tretinoin; C498154:CD38 protein, human; D051997:ADP-ribosyl Cyclase 1